Insiders · Profile

Gollob Jared

Chief Medical Officer at Kymera Therapeutics. Filing since 17 Feb 2021. CIK 0001821198

Company

Date

Role

Action

Shares

Amount

Of holding

KYMR Kymera Therapeutics, Inc.

4 Mar 2026

Chief Medical Officer

Sold at will

4,895

$417.52K

4.0%

KYMR Kymera Therapeutics, Inc.

2 Mar 2026

Chief Medical Officer

Sold at will

5,613

$499.15K

4.4%

KYMR Kymera Therapeutics, Inc.

8 Dec 2025

Chief Medical Officer

Sold on a plan

49,307

$4.37M

31.0%

KYMR Kymera Therapeutics, Inc.

15 Oct 2025

Chief Medical Officer

Sold on a plan

59,576

$3.66M

35.1%

KYMR Kymera Therapeutics, Inc.

13 Oct 2025

Chief Medical Officer

Sold on a plan

3,114

$186.84K

2.6%

KYMR Kymera Therapeutics, Inc.

3 Mar 2025

Chief Medical Officer

Sold at will

5,740

$174.79K

4.6%

KYMR Kymera Therapeutics, Inc.

16 Jul 2024

Chief Medical Officer

Sold on a plan

23,145

$1.06M

19.5%

KYMR Kymera Therapeutics, Inc.

15 Jul 2024

Chief Medical Officer

Sold on a plan

16,455

$742.93K

14.7%

KYMR Kymera Therapeutics, Inc.

4 Mar 2024

Chief Medical Officer

Sold at will

3,344

$139.97K

3.4%

KYMR Kymera Therapeutics, Inc.

27 Feb 2024

Chief Medical Officer

Sold on a plan

400

$18.00K

0.5%

KYMR Kymera Therapeutics, Inc.

9 Feb 2024

Chief Medical Officer

Sold on a plan

46,137

$1.64M

38.2%

KYMR Kymera Therapeutics, Inc.

2 Mar 2023

Chief Medical Officer

Sold, plan not stated

1,298

$40.23K

1.7%

KYMR Kymera Therapeutics, Inc.

2 Nov 2021

Chief Medical Officer

Sold, plan not stated

14,996

$948.06K

37.8%

KYMR Kymera Therapeutics, Inc.

1 Nov 2021

Chief Medical Officer

Sold, plan not stated

42,497

$2.63M

63.3%

KYMR Kymera Therapeutics, Inc.

15 Mar 2021

Chief Medical Officer

Sold, plan not stated

10,305

$620.05K

19.5%

KYMR Kymera Therapeutics, Inc.

11 Mar 2021

Chief Medical Officer

Sold, plan not stated

4,695

$281.94K

9.4%

KYMR Kymera Therapeutics, Inc.

24 Feb 2021

Chief Medical Officer

Sold, plan not stated

8,675

$441.67K

15.4%

KYMR Kymera Therapeutics, Inc.

23 Feb 2021

Chief Medical Officer

Sold, plan not stated

19,285

$957.55K

25.5%

KYMR Kymera Therapeutics, Inc.

22 Feb 2021

Chief Medical Officer

Sold, plan not stated

9,104

$479.13K

10.8%

KYMR Kymera Therapeutics, Inc.

19 Feb 2021

Chief Medical Officer

Sold, plan not stated

8,887

$489.56K

9.5%

KYMR Kymera Therapeutics, Inc.

18 Feb 2021

Chief Medical Officer

Sold, plan not stated

6,499

$363.54K

6.5%

KYMR Kymera Therapeutics, Inc.

17 Feb 2021

Chief Medical Officer

Sold, plan not stated

7,550

$440.84K

7.0%

22 decisions on file.